|
Market Research Report
Imaging Agents - A Worldwide Market Review
| Published by |
BizAcumen, Inc. |
| Published |
November, 2009 |
Product code |
104366 |
| Content info |
Pages: 209 |
| Price |
|
|
Imaging Agents - A Worldwide Market Review published by BizAcumen, Inc. in November, 2009. This report consists of Pages: 209 and the price starts from US $ 2995.
Abstract
Development of contrast agents revolutionized the visualization of organs
within the human body. With their inherent ability to bring discrete organs
and tissues to investigational scrutiny, imaging agents have undergone immense
changes. Technology developments over the last two decades have expanded
application roles of imaging agents. Major imaging technologies that presently
utilize imaging agents include - x-ray/Computed Tomography (CT), Magnetic
Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon
Emission Computed Tomography (SPECT), ultrasound technologies. X-ray contrast
media is paving way for emerging segments such as MRI, Ultrasound and
diagnostic radiopharmaceuticals. The demand for imaging agents moves in sync
with diagnosis and management of several age-related diseases including
cancer, cardiovascular disease, and neurological disease. Reimbursement issues
and procedural volumes are two key factors that significantly impact market
dynamics.
These and other market data and trends are presented in
"Imaging Agents: A Worldwide Market Review" by BizAcumen, Inc. Our reports are
designed to be most comprehensive in geographic coverage and vertical market
analyses
Table of Contents
1. METHODOLOGY
- Study Reliability and Reporting Limitations
- Disclaimers
- Quantitative Techniques & Reporting Level
2. GLOBAL MARKET OVERVIEW AND OUTLOOK
- A Quick Primer On Imaging Agents
- Growth Drivers
- Growth Inhibitors
- Changing Dynamics of Imaging Agents
- Imaging Agents: Significant Growth Ahead
- Rise of Non-Ionizing Imaging Techniques
- Fusion Imaging Modalities: Greater Clinical Benefits
- Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures
- Radiopharmaceuticals-An Exotic Tool
- Nanomaterials Taking the Center Stage
- Gadolinium Coated Nanoparticles- A Promising Imaging Agent
- A Peek Into Pricing Dynamics
- A Synoptic Overview
- Pros & Cons
- Positive Factors Driving Prices
- Negative Factors Bearing Down on Prices
- Reimbursements
- "Under the Umbrella"
- Europe
- United States
3. MARKET TRENDS & ISSUES
- Falling Prices Turn On the Heat
- X-Ray Contrast Media: Declining Sector
- MRI Contrast Media: Playing at Center Court
- Impact Wielded by Ballooning MRI Practices
- Ultrasound Contrast Media: A Rising Star in the Quadrant
- Fledging Market Battles Teething Challenges
- PET: A Prime Growth Driver for Radiopharmaceuticals
- Nuclear Medicine: A Potential Growth Avenue for Radiopharmaceuticals
- Select Cardiology and Oncology Radiopharmaceuticals
4. COMPETITION
- Market Structure
- Key Market Metrics
- Big Guns in the Emerging MRI Market
- Bayer Schering Pharma AG: A Pioneering Developer of MRI Contrast Agents
- Competitive Scenario - A Recent Past Perspective
5. TECHNOLOGY BREAKTHROUGHS
- Molecular Imaging Agents: The Outer Limits
- On Cards: Hyperpolarized Gases as Contrast Agents
- Imaging Agents Make a Welcome Impact in the Field of Alzheimer' s Disease
- Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging
- A New Imaging Agent for Radiopharmaceutical Scans
- Multi-Modal Image Registration: Combating Contrast Medium Inconsistencies
- Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents
6. PRODUCT FACTS
- A. Contrast Media
- X-Ray Contrast Media
- Magnetic Resonance Imaging (MRI) Contrast Media
- Ultrasound Contrast Media
- B. Diagnostic Radiopharmaceuticals
7. TECHNOLOGY DYNAMICS
- New Proprietary Technologies on the Horizon Making Significant Inroads
8. CORPORATE DEVELOPMENTS
- Bristol-Myers Squibb Medical Imaging Adopts New Identity, Lantheus Medical
Imaging
- Cytogen Corporation to Merge Business with EUSA Pharma Inc
- Bracco Group Acquires E-Z-EM
- EPIX Pharmaceuticals to Resubmit New Drug Application (NDA) for Vasovist
- Bayer Schering, FutureChem Ink Licensing Deal
- NuView Radio Pharmaceuticals Inks Agreement for Non-Invasive Imaging Agent
- Bayer to Unleash Radiology Management System
- Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI
- Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals
- Bracco Diagnostics Inks Agreement with HealthTrust Purchasing Group
- Bracco Diagnostics Offers MRI Products to HealthTrust Purchasing Group
- Bayer HealthCare Offers MRI Contrast Agent to HealthTrust
- Bayer HealthCare Extends Contract with Premier
- Bayer HealthCare Sets Off US Operations
- Tyco Healthcare Renamed to Covidien Ltd
- Covidien Offers Imaging Solutions to MedAssets Supply Chain Systems
- Siemens, M.D. Anderson Cancer Center Set up Research Centre
- Bayer, Berlex Merge Operations
- AION Diagnostics Forays Pre-Clinical Imaging Agent Market
- Insight Agents to Launch Generic Contrast Media Solutions In Europe
- Researchers Develop First Biocompatible MRI Contrast Agent
9. MAJOR PLAYERS
- AMAG Pharmaceuticals Inc (USA)
- Amersham Plc (UK)
- Bayer Schering Pharma AG (Germany)
- Bayer HealthCare Pharmaceuticals (US)
- Bracco Group (Italy)
- Covidien (USA)
- Cytogen Corp. (USA)
- Daiichi Sankyo Company Limited (Japan)
- Eisai Co., Ltd. (Japan)
- EPIX Pharmaceuticals Inc. (USA)
- Guerbet Group (France)
- Lantheus Medical Imaging (USA)
10. GLOBAL MARKET ANALYTICS
11. THE UNITED STATES
- Growth Stimulants
- Medical Imaging: Changing the Healthcare Landscape
- Dynamics of Pricing
- Reimbursement Issues
- Medicare
- Magnetic Resonance Imaging
- Regulatory Environment
- Provisions Regarding Off-Label Usage of Contrast Media
- Contrast Media
- X-ray Contrast Media
- MRI Contrast Media
- Managed Care Vs MRI Technology Diffusion
- Ultrasound Contrast Media
- Diagnostic Radiopharmaceuticals
- Market Scenario
- Availability of Isotopes: A Tough Challenge
12. CANADA
- Diagnostic Equipment Market
- LOCM Products Approved in Canada
13. JAPAN
14. EUROPE
- a. France
- b. Germany
- c. The United Kingdom
- d. Italy
- e. Spain
- f. Russia
- g. Rest of Europe
15. ASIA-PACIFIC
- PET Imaging-An Overview
- ANSTO: Leading the Radiopharmaceuticals Market
16. THE MIDDLE EAST
17. LATIN AMERICA
|
